BOSTON, MA — Cilcare , a biotechnology company focused on auditory science, has appointed Kevin Franck, PhD, MBA, as Head of US and General Manager, North America. Based in Washington, DC, Franck will oversee the company’s North American growth strategy, including efforts to expand partnerships involving its clinical research and development platforms....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate leadership announcement with no direct clinical or patient-care implications at this time.
Cilcare's investment in senior North American leadership signals the company is accelerating its push to bring auditory biotech research and services into the U.S. market, which could eventually affect clinical trial access and research partnerships for audiologists.
- 01Cilcare has appointed Kevin Franck, PhD, MBA, as Head of US and General Manager, North America.
- 02Franck is described as a hearing industry veteran, bringing established sector expertise.
- 03The hire is explicitly tied to leading Cilcare's North American expansion strategy.
- 04Cilcare is a biotechnology company focused on auditory science research.
Kevin Franck, PhD, MBA, is a hearing industry veteran appointed to lead Cilcare's North American expansion.
press releasesupported
